Repro-Med Systems, Inc. (NASDAQ:REPR) Director Joseph M. Jr. Manko bought 136,248 shares of the business’s stock in a transaction on Friday, September 30th. The shares were purchased at an average cost of $0.44 per share, for a total transaction of $59,949.12. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Shares of Repro-Med Systems, Inc. (NASDAQ:REPR) opened at 0.44 on Wednesday. The firm’s 50-day moving average is $0.41 and its 200 day moving average is $0.38. Repro-Med Systems, Inc. has a 52 week low of $0.28 and a 52 week high of $0.59. The firm has a market capitalization of $16.70 million and a P/E ratio of 36.67.

Insider Buying and Selling by Quarter for Repro-Med Systems (NASDAQ:REPR)

About Repro-Med Systems

REPRO MED SYSTEMS, INC. (RMS) designs, manufactures and markets medical devices for the ambulatory infusion market and emergency medical applications. The Company’s products include FREEDOM60 Syringe Infusion System (FREEDOM60), RMS HIGH-Flo Subcutaneous Safety Needle Sets (HIgH-Flo), RES-Q-VAC Portable Medical Suction System (RES-Q-VAC) and On-Line Calculator.

5 Day Chart for NASDAQ:REPR

Receive News & Stock Ratings for Repro-Med Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repro-Med Systems Inc. and related stocks with our FREE daily email newsletter.